OBJECTIVES: Use of lidocaine as part of a multimodal approach to postoperative pain management has increased in adults; however, limited information is available regarding safety and tolerability in pediatrics. This study's primary objective was to evaluate the incidence of adverse effects related to lidocaine infusions in a sample of pediatric patients. METHODS: A retrospective analysis was conducted in pediatric patients receiving lidocaine infusion for the management of postoperative analgesia at the University of Virginia Health System. RESULTS: A total of 50 patients with 51 infusions were included in the final analysis. The median patient age was 14 years (range, 2-17 years). The most frequent surgeries were spinal fusion (30%), Nuss procedure for pectus excavatum (16%), and nephrectomy (6%). The mean ± SD starting rate was 13.6 ± 6.5 mcg/kg/min. The mean infusion rate during administration was 15.2 ± 6.3 mcg/kg/min, with 14.4 ± 6.2 mcg/kg/min at discontinuation. The mean length of therapy was 30.6 ± 22 hours. A total of 12 infusions (24%) were associated with adverse effects, primarily neurologic ones, including paresthesias in the upper extremities (10%) and visual disturbances (4%). The average time to onset was 16.2 ± 15.2 hours. Seven infusions were discontinued, whereas the remaining infusions resulted in either dose reduction or continuation without further incident. No patients experienced toxicity requiring treatment with lipid emulsion. CONCLUSIONS: In this sample, lidocaine was a well-tolerated addition to multimodal postoperative pain management in the pediatric population. Although adverse effects were common, they were mild and resolved with either dose reduction or discontinuation.
OBJECTIVES: Use of lidocaine as part of a multimodal approach to postoperative pain management has increased in adults; however, limited information is available regarding safety and tolerability in pediatrics. This study's primary objective was to evaluate the incidence of adverse effects related to lidocaine infusions in a sample of pediatric patients. METHODS: A retrospective analysis was conducted in pediatric patients receiving lidocaine infusion for the management of postoperative analgesia at the University of Virginia Health System. RESULTS: A total of 50 patients with 51 infusions were included in the final analysis. The median patient age was 14 years (range, 2-17 years). The most frequent surgeries were spinal fusion (30%), Nuss procedure for pectus excavatum (16%), and nephrectomy (6%). The mean ± SD starting rate was 13.6 ± 6.5 mcg/kg/min. The mean infusion rate during administration was 15.2 ± 6.3 mcg/kg/min, with 14.4 ± 6.2 mcg/kg/min at discontinuation. The mean length of therapy was 30.6 ± 22 hours. A total of 12 infusions (24%) were associated with adverse effects, primarily neurologic ones, including paresthesias in the upper extremities (10%) and visual disturbances (4%). The average time to onset was 16.2 ± 15.2 hours. Seven infusions were discontinued, whereas the remaining infusions resulted in either dose reduction or continuation without further incident. No patients experienced toxicity requiring treatment with lipid emulsion. CONCLUSIONS: In this sample, lidocaine was a well-tolerated addition to multimodal postoperative pain management in the pediatric population. Although adverse effects were common, they were mild and resolved with either dose reduction or discontinuation.
Authors: Peter Kranke; Johanna Jokinen; Nathan Leon Pace; Alexander Schnabel; Markus W Hollmann; Klaus Hahnenkamp; Leopold H J Eberhart; Daniel M Poepping; Stephanie Weibel Journal: Cochrane Database Syst Rev Date: 2015-07-16
Authors: Kathleen Gibbons; Andrea DeMonbrun; Elizabeth J Beckman; Patricia Keefer; Deb Wagner; Margaret Stewart; D'Anna Saul; Stephanie Hakel; My Liu; Matthew Niedner Journal: Pediatr Blood Cancer Date: 2016-01-19 Impact factor: 3.167
Authors: Roger Chou; Debra B Gordon; Oscar A de Leon-Casasola; Jack M Rosenberg; Stephen Bickler; Tim Brennan; Todd Carter; Carla L Cassidy; Eva Hall Chittenden; Ernest Degenhardt; Scott Griffith; Renee Manworren; Bill McCarberg; Robert Montgomery; Jamie Murphy; Melissa F Perkal; Santhanam Suresh; Kathleen Sluka; Scott Strassels; Richard Thirlby; Eugene Viscusi; Gary A Walco; Lisa Warner; Steven J Weisman; Christopher L Wu Journal: J Pain Date: 2016-02 Impact factor: 5.820
Authors: George Francisco S Santos; Luan Oliveira Ferreira; Bruna Gerrits Mattos; Eliniete J Fidelis; Alisson S de Souza; Paula S Batista; Cecilia A F Manoel; Diego Arthur C Cabral; Vanessa Jóia de Mello; Dielly Catrina Favacho Lopes; Moisés Hamoy Journal: Brain Behav Date: 2020-12-25 Impact factor: 3.405
Authors: Roberta Esteves Vieira de Castro; Miguel Rodríguez-Rubio; Maria Clara de Magalhães-Barbosa; Arnaldo Prata-Barbosa; Jaimee Holbrook; Pradip Kamat; Anne Stormorken Journal: Front Pediatr Date: 2022-08-30 Impact factor: 3.569
Authors: Doralina L Anghelescu; Kyle J Morgan; Michael J Frett; Diana Wu; Yimei Li; Yuanyuan Han; Elizabeth A Hall Journal: Pediatr Blood Cancer Date: 2021-07-15 Impact factor: 3.167
Authors: Shabana Z Shafy; Rebecca Miller; Joshsua C Uffman; Joseph D Tobias; Mike Fetzer; Andrew B Nordin; Brian Kenney; Hina Walia; Giorgio Veneziano Journal: Pediatr Qual Saf Date: 2019-12-05